CoolSculpting®

Actual patient. Treatment results may vary.

CoolSculpting® is the leading, non-invasive, body contouring treatment option to reduce fat1‡.

CoolSculpting® uses cryolipolysis, a non-surgical procedure to reduce subcutaneous or ‘pinchable’ fat cells2,3. It works by cooling targeted stubborn fat cells to induce the death of these cells without affecting surrounding tissue4*.

CoolSculpting® eliminate that stubborn fat that’s difficult to get rid of, even with diet and exercise5-7 from different areas, up to 9 areas, around the body*2,10-22 with minimal expected downtime after treatment8,9.

 

Product Status: Medical Device
Device Technique: Cryolipolysis

For Consumers

Consumer Product Questions

Consult coolsculpting-mena

Report a Side Effect or Adverse Event

PLSProductSurveillanceteam@abbvie.com

For Providers

Providers User Manual

Providers CoolSculpting® User Manual

Provider Product Scientific Questions

From Gulf countries
From Kingdom of Saudi Arabia

CoolSculpting®, the CoolSculpting® logo, and the Snowflake design are registered trademarks of Allergan Aesthetics. CoolSculpting® systems, applicators and cards are medical devices Class I or Class IIa CE0197. ZELTIQ® Is part of Allergan Aesthetics, an AbbVie company. All rights reserved.

The suitability of CoolSculpting® treatment on an individual patient basis should always be considered as part of the assessment and consultation process. CoolSculpting® is not suitable for all patients. Please consult the Directions for Use prior to the procedure. Patient results may vary.

‡ Based on HCP tracking market research in the US, UK, Germany, Canada, Brazil, China, and Australia (N=526), and global market research of the overall body shaping and skin tightening market
* Data obtained from cryolipolysis investigations using a pig model
1 Allergan. Unpublished data. INT-CSC-1950062. CoolSculpting® market research. July 2019
2 Kilmer SL, et al. Lasers Surg Med 2017;49(1):63–68.
3 Kilmer SL, et al. Lasers in Surgery and Medicine 2016;48:3–13
4.Zelickson B, et al. Am Soc Dermatol Surg. 2009; 35:1462-1470.
5. CoolSculpting® system user manual (BRZ-101-TUM-EN2-J). December 2016.
6. Duncan DI & Chubaty R. Aesthet Surg J. 2006; 26:575-585.
7. Schlessinger J, et al. Skin Med. 2013; 11:27-31.
8.Krueger N, et al. Clin Cos Invest Derm. 2014; 7:201-205.
9. Nelson AA & Avram MM. Fat removal: Invasive and noninvasive body contouring. 1st Edition. 2015. Chichester, UK: John Wiley & Sons, Ltd.
10. Shek SY et al. Lasers Surg Med. 2012; 44:125-130.

11. Stevens WG & Bachelor EP. Aesthetic Surg J. 2015; 35:66-71.
12. Carruthers JD, et al. Dermatol Surg. 2017; 43:940-949.
13. Bernstein EF & Bloom JD. JAMA Facial Plastic Surg. 2017; doi:10.1001/jamafacial.2017.0102.
14. Sasaki GH, et al. Aesthetic Surg J. 2014; 34:420-431.
15. Zelickson BD, et al. Lasers Surg Med. 2015; 47:120-27.
16. Garibayan L, et al. Lasers Surg Med. 2014; 46:75-80.
17. Wanitphakdeedecha R, et al. Lasers Med Sci. 2015; 30:2165-2169.
18. Lee SJ, et al. J Cos Laser Ther. 2016; 18:126-129.
19. Boey GE & Wasilenchuck JL. Dermatol Surg. 2014; 0:1-6.
20. Kilmer SL. Lasers Surg Med. 2017. 49:63-68.
21. Zelickson B, et al. Am Soc Dermatol Surg. 2009; 35:1462-1470.
22. FDA. Indications for Use Zeltiq CoolSculpting® System. November 2017. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf17/K172144.pdf (accessed February 2018).